Advertisement
Screener

Celldex Therapeutics, Inc. (CLDX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Celldex Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Celldex Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $210.94M went out.
  • Fiscal year ended 2025-12-31: from investing, $209.07M came in.
  • Fiscal year ended 2025-12-31: from financing, $2.39M came in.
  • Fiscal year ended 2025-12-31: change in cash, $515.00K came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$210.94M$209.07M$2.39M$515.00K
2024-12-31-$157.78M-$290.13M$432.30M$9.15M*-$6.46M
2023-12-31-$107.29M-$105.78M$216.22M$2.24M*$5.38M
2022-12-31-$103.73M$89.94M$4.08M-$9.71M
2021-12-31-$60.91M-$216.16M$269.89M$2.48M*-$4.69M
2020-12-31-$40.40M-$98.22M-$2.96M$2.96M$170.79M$32.60M
2019-12-31-$46.41M$17.08M$16.25M-$13.08M
2018-12-31-$75.23M$29.82M$29.02M-$15.98M
2017-12-31-$99.93M$46.47M$51.02M-$2.17M
2016-12-31-$113.04M$68.91M$13.95M$536.00K*-$29.65M
2015-12-31-$98.89M-$50.19M$188.84M$4.31M*$44.09M
2014-12-31-$101.54M-$41.01M$1.17M-$141.38M
2013-12-31-$67.67M-$77.42M-$11.03M$295.70M$4.93M*$144.50M
2012-12-31-$49.78M-$16.98M-$3.97M$83.78M
2011-12-31-$35.66M-$2.15M$5.00M$36.02M-$12.59M*
2010-12-31-$30.37M-$16.16M$10.00M$1.01M
2009-12-31-$29.87M$45.09M$668.00K-$3.13M*

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$57.41M*-$255.52M*$825.00K*$323.83M*
2026-03-31-$65.59M$72.12M$327.00K$6.86M
2025-12-31-$63.94M*$55.42M*$1.35M*
2025-09-30-$48.63M*$60.85M*$774.00K*
2025-06-30-$44.01M*$49.85M*$63.00K*
2025-03-31-$54.37M$42.95M$202.00K-$11.22M
2024-12-31-$32.48M*$24.05M*$0.00*
2024-09-30-$55.34M*$47.76M*$0.00*$1.24M*
2024-06-30-$29.33M*-$46.72M*$0.00*$3.71M*
2024-03-31-$40.64M-$315.21M$432.30M$3.81M*$80.26M
2023-12-31-$32.53M*-$171.16M*$1.15M*$216.22M*
2023-09-30-$18.99M*$11.65M*$257.00K*
2023-06-30-$27.20M*$1.16M*$133.00K*
2023-03-31-$28.57M$52.57M$694.00K$24.69M
2022-12-31-$21.76M*$31.21M*$1.40M*
2022-09-30-$35.19M*$23.07M*$2.31M*
2022-06-30-$22.24M*$25.28M*$71.00K*
2022-03-31-$24.53M$10.38M$304.00K-$13.85M
2021-12-31-$14.52M*-$18.94M*$0.00*
2021-09-30-$16.37M*-$226.79M*$2.00M*$269.89M*
2021-06-30-$11.93M*-$13.91M*-$25.00K*
2021-03-31-$18.08M$43.49M$74.00K$25.48M
2020-12-31-$5.21M*$30.85M*$0.00*$0.00*-$172.00K*
2020-09-30-$11.86M*-$42.51M*$0.00*$0.00*$4.30M*
2020-06-30-$11.22M*-$108.53M*$165.05M*
2020-03-31-$12.11M$21.96M$1.61M$11.49M
2019-12-31-$11.00M*$3.22M*$2.42M*
2019-09-30-$11.14M*$5.52M*$2.46M*
2019-06-30-$11.04M*-$7.96M*$7.21M*
2019-03-31-$13.23M$16.30M$4.15M$7.22M
2018-12-31-$15.43M*$3.35M*$3.57M*-$8.51M*
2018-09-30-$14.39M*-$2.22M*$5.49M*-$11.07M*
2018-06-30-$17.39M*$13.19M*$8.27M*$4.07M*
2018-03-31-$28.02M$15.49M$11.69M-$464.00K
2017-12-31-$19.52M*-$13.38M*$18.38M*-$14.45M*
2017-09-30-$24.36M*$1.67M*$11.15M*-$11.43M*
2017-06-30-$20.79M*$35.78M*$8.67M*$23.66M*
2017-03-31-$35.26M$22.40M$12.82M$36.00K
2016-12-31-$20.35M*$27.78M*$3.28M*$10.72M*
2016-09-30-$23.95M*$14.92M*$8.12M*-$739.00K*
2016-06-30-$33.83M*$667.00K*$69.00K*$2.55M*-$30.54M*
2016-03-31-$34.90M$25.54M$280.00K-$9.08M
2015-12-31-$13.74M*$18.74M*$0.00*$5.32M*
2015-09-30-$27.79M*$12.26M*$0.00*$736.00K*-$14.79M*
2015-06-30-$24.76M*-$16.16M*$66.00K*-$40.59M*
2015-03-31-$32.59M-$65.03M$188.77M$2.98M*$94.15M
2014-12-31-$22.21M*$17.70M*$11.00K*-$4.50M*
2014-09-30-$26.59M*$18.02M*$304.00K*-$8.27M*
2014-06-30-$20.86M*$4.60M*$154.00K*
2014-03-31-$31.88M-$81.33M$702.00K
2013-12-31-$14.96M*-$13.82M*$181.51M*$2.04M*
2013-09-30-$17.45M*$5.56M*$0.00*$622.00K*
2013-06-30-$18.06M*-$22.58M*-$9.71M*$0.00*$620.00K*
2013-03-31-$17.20M-$46.58M$114.19M
2012-12-31-$13.33M*-$4.54M*-$1.32M*$20.91M*
2012-09-30-$10.94M*$5.99M*-$1.32M*$10.91M*
2012-06-30-$11.96M*$9.08M*$28.00K*-$1.34M*
2012-03-31-$13.55M-$27.51M$51.93M
2011-12-31-$9.37M*$8.04M*$0.00*$143.00K*
2011-09-30-$8.06M*$10.35M*$0.00*-$9.00K*
2011-06-30-$9.37M*-$25.82M*$0.00*$35.88M*
2011-03-31-$8.86M$5.27M$5.00M-$12.55M*
2010-12-31-$6.01M*$7.51M*$13.00K*$9.95M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93